Video Presentation

LD Micro Main Event Conference on Wednesday December 5, 2018

VBX-100

Dr. Brandon Zipp, Director of Research & Development and a Scientific Co-founder of Vitality Biopharma, Inc., presents how Δ9-Tetrahydrocannabinol (THC) is a promising candidate for treatment of gastrointestinal (GI) conditions, including inflammatory bowel disease (IBD).